OnKure Therapeutics, Inc DEFA14A, filed Apr 22, 2022
OnKure Therapeutics, Inc. (OKUR)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials |
| ☐ | Soliciting Material under § 240.14a-12 |
Reneo Pharmaceuticals, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
| ☒ | No fee required |
| ☐ | Fee paid previously with preliminary materials |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
Reneo Pharmaceuticals
P.O. BOX 8016, CARY, NC
27512-9903
Reneo Pharmaceuticals, Inc.
Important Notice Regarding the
Availability of Proxy Materials
Stockholders Meeting to be held on June 1, 2022
For Stockholders of record as of April 4, 2022
This communication presents only an
overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the
proxy materials before voting.
To view the proxy materials, and to obtain directions to attend the meeting, go to: www.proxydocs.com/RPHM
To vote your proxy while visiting this site, you will need the 12 digit control number in the box below.
Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on
the internet.
For a convenient way to view proxy materials and VOTE go to www.proxydocs.com/RPHM
Have the 12 digit control number located in the shaded box above available when you access the website and follow the instructions.
If you want to receive a paper or e-mail copy of the proxy material, you must request one. There is no charge to you for requesting a copy.
In order to receive a paper package in time for this year’s meeting, you must make this request on or before May 20, 2022.
To order paper materials, use
one of the following methods.
INTERNET www.investorelections.com/RPHM TELEPHONE (866) 648-8133 * E-MAIL paper@investorelections.com
When requesting via the Internet or telephone you will need the 12 digit control number
located in the shaded box above.
* If requesting material by e-mail, please send a blank
e-mail with the 12 digit control number (located above) in the subject line. No other requests, instructions OR other inquiries should be included with your e-mail
requesting material.
Reneo Pharmaceuticals, Inc.
Meeting Type: Annual Meeting
of Stockholders Date: Wednesday, June 1, 2022
Time: 11:30 AM, Pacific Time
Place: Annual Meeting to be held live via the internet - please visit www.proxydocs.com/RPHM for more details.
To attend the meeting you must register by May 31, 2022 7:30 AM Pacific Time online at www.proxydocs.com/RPHM.
SEE REVERSE FOR FULL AGENDA
Reneo Pharmaceuticals, Inc.
Annual Meeting of
Stockholders
THE BOARD OF DIRECTORS RECOMMENDS A VOTE:
FOR all of the
nominees for director listed below and FOR Proposal 2
PROPOSAL
1. To elect
the two Class I directors named herein to hold office until the Company’s 2025 annual meeting of stockholders.
1.01 Eric M. Dube, Ph.D.
1.02 Paul W. Hoelscher
2. To ratify the selection by the Audit Committee of the Board of
Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2022.
NOTE: To conduct any other business properly brought before the Annual Meeting.